Related Experiment Videos
Association Between Heart Failure Etiology and All-Cause Mortality with Sex-Specific Considerations: Insights from
Michał Tarnowski1, Robert Morawiec2, Agata Galas3
1Department of Cardiology, Holy Spirit Specialist Hospital, 27-600 Sandomierz, Poland.
Insights
This study found that both ischemic and non-ischemic heart failure (HF) have similar mortality risks. Gender did not significantly impact survival rates within these heart failure (HF) categories.
Area of Science:
- Cardiology
- Clinical Research
- Epidemiology
Background:
- Heart failure (HF) prognosis is influenced by etiology and patient sex.
- Understanding gender-specific impacts of ischemic HF is crucial.
Purpose of the Study:
- To evaluate the impact of ischemic heart failure (HF) etiology on prognosis, with a focus on gender differences.
- To compare all-cause mortality between ischemic and non-ischemic HF etiologies stratified by sex.
Main Methods:
- Prospective, multicenter cohort study (HEROES) including 1410 hospitalized and outpatient patients.
- Data collected between April 2022 and January 2024.
- Primary endpoint: all-cause mortality.
Main Results:
- Ischemic HF etiology was more prevalent in males (46.0%) than females (28.5%).
- No significant difference in all-cause mortality was observed between ischemic and non-ischemic HF etiologies (aHR 1.16; p=0.363).
- Sex-stratified analysis showed no significant mortality differences between women and men within either HF etiology.
Conclusions:
- Ischemic and non-ischemic heart failure (HF) etiologies are associated with comparable all-cause mortality risks.
- No significant sex-based differences in mortality were found within ischemic or non-ischemic HF categories.
Abstract:
Background: Heart failure (HF) is a complex clinical syndrome, and its prognosis depends on many factors, including its etiology and the patient's sex. We aimed to perform gendered evaluations on ischemic etiology's impact on HF prognosis. Methods: Hospitalized patients and outpatients were enrolled in the Heart Failure Observational Study (HEROES), which is a prospective, multicenter cohort study, between April 2022 and January 2024. The primary endpoint was all-cause mortality. Results: Among 1410 patients included in the analysis (28.4% females and 71.6% males), 41.1% had ischemic HF etiology, and 58.9% had non-ischemic HF etiology. Ischemic etiology was identified in 28.5% of females and 46.0% of males; p < 0.001. The adjusted hazard ratio (aHR) was 1.16 (95% CI 0.85-1.58; p = 0.363) for all-cause mortality in the non-ischemic group relative to the ischemic reference category. The aHR for all-cause mortality in women relative to men was 1.14 (95% CI: 0.67-1.94; p = 0.633) for ischemic HF and 0.85 (95% CI: 0.56-1.27; p = 0.420) for non-ischemic HF. Conclusions: We found that ischemic and non-ischemic etiologies are associated with comparable all-cause mortality risk in patients with HF. Sex-stratified analyses revealed no significant mortality differentials between women and men within either etiologic category.
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management